Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Demographics and Clinical Profile of Hemophilia Patients in China - Results from a Cross-Sectional, Community-Based Survey

Feng Xue, Chun Chang, Karina Chin Po Hsu, Jing Sun, Xinsheng Zhang, Shujie Wang, Jingsheng Wu, Rong Chen, Danni Shi, Felix Cao, Renchi Yang

Blood (2024) 144 (Supplement 1): 5485.

https://doi.org/10.1182/blood-2024-207783

Published: 2024

Journal Articles

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Blood (2023) 142 (Supplement 1): 2624.

https://doi.org/10.1182/blood-2023-174698

Published: 2023

Journal Articles

Pathogenic Germline Variants in Multiple Myeloma

Santiago Thibaud, Aaron Etra, Ryan Subaran, Zachry Soens, Scott Newman, Rong Chen, Ajai Chari, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, David T. Melnekoff, Shambavi Richard, Joshua Richter, Larysa Sanchez, Kuan-lin Huang, Alessandro Lagana, Samir Parekh, Kenan Onel

Blood (2021) 138 (Supplement 1): 399.

https://doi.org/10.1182/blood-2021-151495

Published: 2021

Journal Articles

A Phase I Study Combining CDK2/9 Inhibitor CYC065 with Venetoclax, a BCL2 Inhibitor, to Treat Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

William G. Wierda, MD PhD, Seung Tae Lee, MD PhD, Rong Chen, PhD, Daniella Zheleva, PhD, David Blake, PhD, Judy H Chiao, MD, William Plunkett, PhD

Blood (2019) 134 (Supplement_1): 1761.

https://doi.org/10.1182/blood-2019-128956

Published: 2019

Journal Articles

Genome-Wide Mapping and Subtype Classification of Long Non-Coding RNA in Acute Myeloid Leukemia

Rong Chen, PhD, Gabriel G Malouf, MD PhD, Jianping Zhang, PhD, Xuelin Huang, PhD, John N Weinstein, MD PhD, Jean-Philippe Spano, MD PhD, Jeffrey J. Molldrem, MD, William Plunkett, PhD, Xiaoping Su, PhD

Blood (2014) 124 (21): 2355.

https://doi.org/10.1182/blood.V124.21.2355.2355

Published: 2014

Journal Articles

Activities and Mechanism Based Combinations Of Omacetaxine In Acute Myeloid Leukemia

Rong Chen, PhD, Bonnie Leung, Yuling Chen, MPH, MD, William Plunkett, PhD

Blood (2013) 122 (21): 1288.

https://doi.org/10.1182/blood.V122.21.1288.1288

Published: 2013

Journal Articles

MRx102, a Novel Triptolide Analogue, Has Low Nanomolar Activity Against AML Stem/Progenitor Cells in Vitro and in a Murine Model of AML

Bing Z Carter, Ph.D., Duncan H Mak, M.S., Yuxie Shi, John M. Fidler, Ph.D., Rong Chen, PhD, Xiaoyang Ling, PhD, William Plunkett, PhD, Michael Andreeff, M.D., Ph.D.

Blood (2011) 118 (21): 1547.

https://doi.org/10.1182/blood.V118.21.1547.1547

Published: 2011

Journal Articles

Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia

Rong Chen, Lei Guo, Yuling Chen, Yingjun Jiang, William G. Wierda, William Plunkett

Blood (2011) 117 (1): 156–164.

https://doi.org/10.1182/blood-2010-01-262808

Published: 2011

Includes: Supplemental data

Journal Articles

Reducing Mcl-1 by Homoharringtonine Induces Apoptosis In Chronic Lymphocytic Leukemia Cells

Rong Chen, PhD, Lei Guo, MD, PhD, Yuling Chen, Yingjun Jiang, PhD, William G. Wierda, MD, PhD, William Plunkett, PhD

Blood (2010) 116 (21): 2896.

https://doi.org/10.1182/blood.V116.21.2896.2896

Published: 2010

Journal Articles

Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance

Antonina V. Kurtova, Kumudha Balakrishnan, Rong Chen, Wei Ding, Susanne Schnabl, Maite P. Quiroga, Mariela Sivina, William G. Wierda, Zeev Estrov, Michael J. Keating, Medhat Shehata, Ulrich Jäger, Varsha Gandhi, Neil E. Kay, William Plunkett, Jan A. Burger

Blood (2009) 114 (20): 4441–4450.

https://doi.org/10.1182/blood-2009-07-233718

Published: 2009

Includes: Supplemental data

Journal Articles

Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia

Rong Chen, William G. Wierda, Sherri Chubb, Rachael E. Hawtin, Judith A. Fox, Michael J. Keating, Varsha Gandhi, William Plunkett

Blood (2009) 113 (19): 4637–4645.

https://doi.org/10.1182/blood-2008-12-190256

Published: 2009

Journal Articles

Mechanism of Action of SNS-032, a Novel Cyclin Dependent Kinase Inhibitor, in Chronic Lymphocytic Leukemia: Comparison with Flavopiridol.

Rong Chen, William G. Wierda, Sherri Benaissa, Ute Hoch, Rachael E. Hawtin, Judith A. Fox, Michael J. Keating, Varsha Gandhi, William Plunkett

Blood (2007) 110 (11): 3112.

https://doi.org/10.1182/blood.V110.11.3112.3112

Published: 2007

Journal Articles

Point Mutation and Alternative Splicing in the ABL Kinase Domain as a Mechanism for Imatinib Resistance.

Rong Chen, Steven Potts, Wanlong Ma, Hagop Kantarjian, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4814.

https://doi.org/10.1182/blood.V108.11.4814.4814

Published: 2006

Journal Articles

A Phase II Study of Intravenous (IV) Homoharringtonine (HHT) and Imatinib (IM) in Patients (pts) with Chronic Myeloid Leukemia (CML).

Alfonso Quintas-Cardama, MD, Hagop M. Kantarjian, MD, William Wierda, MD, Alessandra Ferrajoli, MD, Rong Chen, MD, Farhad Ravandi, MD, William Plunkett, MD, Jorge Cortes, MD

Blood (2006) 108 (11): 2174.

https://doi.org/10.1182/blood.V108.11.2174.2174

Published: 2006

Journal Articles

Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death

Rong Chen, Michael J. Keating, Varsha Gandhi, William Plunkett

Blood (2005) 106 (7): 2513–2519.

https://doi.org/10.1182/blood-2005-04-1678

Published: 2005

NARROW

Demographics and Clinical Profile of Hemophilia Patients in China - Results from a Cross-Sectional, Community-Based Survey

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Pathogenic Germline Variants in Multiple Myeloma

A Phase I Study Combining CDK2/9 Inhibitor CYC065 with Venetoclax, a BCL2 Inhibitor, to Treat Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Genome-Wide Mapping and Subtype Classification of Long Non-Coding RNA in Acute Myeloid Leukemia

Activities and Mechanism Based Combinations Of Omacetaxine In Acute Myeloid Leukemia

MRx102, a Novel Triptolide Analogue, Has Low Nanomolar Activity Against AML Stem/Progenitor Cells in Vitro and in a Murine Model of AML

Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia

Reducing Mcl-1 by Homoharringtonine Induces Apoptosis In Chronic Lymphocytic Leukemia Cells

Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance

Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia

Mechanism of Action of SNS-032, a Novel Cyclin Dependent Kinase Inhibitor, in Chronic Lymphocytic Leukemia: Comparison with Flavopiridol.

Point Mutation and Alternative Splicing in the ABL Kinase Domain as a Mechanism for Imatinib Resistance.

A Phase II Study of Intravenous (IV) Homoharringtonine (HHT) and Imatinib (IM) in Patients (pts) with Chronic Myeloid Leukemia (CML).

Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only